News tagged with clopidogrel
Related topics: patients , heart attack , thrombosis , aspirin , blood clots
Ticagrelor effective at reducing first, as well as recurrent and overall cardiovascular events
Ticagrelor, a potent anti-platelet medication, was approved by the Food and Drug Administration in the summer of 2011 and is known to significantly reduce the risk of stroke, heart attack, vascular death and death overall ...
Cardiology
Mar 26, 2012 |
not rated yet |
0
New class of platelet blockers proves effective in phase III trial
Adding vorapaxar, an investigational platelet blocker, to standard antiplatelet therapy significantly reduces the risk of recurrent cardiovascular events in patients with known atherosclerosis, a hardening and narrowing of ...
Cardiology
Mar 26, 2012 |
not rated yet |
0
|
Complications in patients undergoing percutaneous coronary intervention tend to occur within first 30 days
Percutaneous coronary intervention (PCI), also known as coronary angioplasty or angioplasty, is a procedure used to treat acute coronary syndromes. PCI involves opening a blocked blood vessel by threading and inflating a ...
Cardiology
Mar 24, 2012 |
not rated yet |
0
|
Aspirin as good as Plavix for poor leg circulation: study
(HealthDay) -- Aspirin works as well as Plavix in patients with blocked leg arteries, a new European study finds.
Cardiology
Feb 22, 2012 |
5 / 5 (1) |
1
Clopidogrel with aspirin doesn't prevent more small strokes, may increase risk of bleeding, death
The anti-blood clot regimen that adds the drug clopidogrel (Plavix) to aspirin treatment is unlikely to prevent recurrent strokes and may increase the risk of bleeding and death in patients with subcortical stroke according ...
Cardiology
Feb 03, 2012 |
not rated yet |
0
Drug helps maintain platelet inhibition and anti-clotting levels prior to cardiac surgery
Patients who discontinued use of an antiplatelet agent such as clopidogrel prior to undergoing cardiac surgery to lower their bleeding risk and received intravenously the platelet inhibitor cangrelor achieved a higher rate ...
Surgery
Jan 17, 2012 |
not rated yet |
0
Allergy to Plavix can be overcome: study
Allergies to Plavix, also know by its chemical name, Clopidogrel occur in about six percent of patients given the drug, vital for the prevention of life-threatening stent thrombosis after angioplasty and percutaneous coronary ...
Medications
Jan 16, 2012 |
not rated yet |
0
Genetic test for Plavix use may be unneeded: study
A new study published Wednesday cast doubt on the usefulness of a genetic test for patients taking the anti-coagulant drug Plavix, calling into question last year's FDA warning about the blood thinner.
Medications
Dec 29, 2011 |
not rated yet |
0
Analysis does not support genetic test before use of anti-clotting drug
Although the U.S. Food and Drug Administration (FDA) has recommended that a certain type of genetic testing (for the genotype CYP2C19) be considered before prescribing the drug clopidogrel to identify individuals who may ...
Genetics
Dec 27, 2011 |
not rated yet |
0
|
Increasing dosage of clopidogrel for patients with genetic variation improves response to medication
Among patients with stable cardiovascular disease who have a genetic variation that diminishes the response to the antiplatelet drug clopidogrel, tripling the standard daily dosage of this medication resulted in improved ...
Cardiology
Nov 16, 2011 |
not rated yet |
0
Impact of timing on carotid artery stenting after stroke or transient ischemic attack
A recent study found no significant difference in the outcome for patients who received carotid artery stenting (CAS) at more than 30 days post-transient ischemic attack (TIA) or stroke versus those who received CAS at 30 ...
Cardiology
Nov 14, 2011 |
not rated yet |
0
Results of the TRIGGER-PCI trial reported at TCT 2011
A clinical trial comparing prasugrel to clopidogrel for patients with high on-clopidogrel platelet reactivity (HCPR) following percutaneous coronary intervention (PCI) was ended early due to relatively few occurrences of ...
Cardiology
Nov 09, 2011 |
5 / 5 (1) |
0
30-day results of ADAPT-DES registry reported at TCT 2011
The relationship of platelet responsiveness to antiplatelet medications; and, the correlation of poor response, and overall platelet aggregation while on dual antiplatelet therapy to the risk of drug-eluting stent thrombosis ...
Cardiology
Nov 09, 2011 |
not rated yet |
0
World's first bedside genetic test proves effective
Tailored anti-platelet therapy, made possible through a novel point-of-care genetic test, optimizes treatment for patients who carry a common genetic variant, researchers at the University of Ottawa Heart Institute (UOHI) ...
Genetics
Nov 09, 2011 |
not rated yet |
0
|
Researchers find gene variants that cause stent thrombosis in people with coronary artery disease
In a first-of-its-kind study, researchers from Mount Sinai School of Medicine have discovered several gene variants contributing to early stent thrombosis (ST), a devastating and often deadly complication after coronary stent ...
Genetics
Oct 25, 2011 |
not rated yet |
0
|
